Canada markets closed

MDxHealth SA (0O8G.L)

LSE - LSE Delayed Price. Currency in EUR
Add to watchlist
3.0198-0.1804 (-5.64%)
At close: 06:16PM BST
Currency in EUR

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-52.82%
S&P500 52-Week Change 322.38%
52 Week High 36.5400
52 Week Low 30.0000
50-Day Moving Average 32.7363
200-Day Moving Average 33.1467

Share Statistics

Avg Vol (3 month) 31.14k
Avg Vol (10 day) 3205
Shares Outstanding 559.94M
Implied Shares Outstanding 6N/A
Float 816.98M
% Held by Insiders 12.63%
% Held by Institutions 140.36%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 20.1:1
Last Split Date 3Nov 14, 2023

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -52.97%
Operating Margin (ttm)-33.30%

Management Effectiveness

Return on Assets (ttm)-11.56%
Return on Equity (ttm)-217.59%

Income Statement

Revenue (ttm)75.33M
Revenue Per Share (ttm)2.76
Quarterly Revenue Growth (yoy)34.90%
Gross Profit (ttm)N/A
EBITDA -18.09M
Net Income Avi to Common (ttm)-39.9M
Diluted EPS (ttm)-0.2150
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.49M
Total Cash Per Share (mrq)0.53
Total Debt (mrq)41.1M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.69
Book Value Per Share (mrq)-0.04

Cash Flow Statement

Operating Cash Flow (ttm)-22.74M
Levered Free Cash Flow (ttm)-20.72M